Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × COVID-19 × Interferon-alpha × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 10 Carcinoma, Renal Cell 9 Kidney Neoplasms 7 Leukemia, Myeloid, Chronic-Phase 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Leukemia 6 Multiple Myeloma 4 Lymphoma, Mantle-Cell 3 Lymphoma 3 Rectal Neoplasms 2 Neoplasms, Plasma Cell 2 Lymphoma, Follicular 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

tocilizumab 1 selinexor 1 lenzilumab 1 cilgavimab and tixagevimab drug combination 1 Standard of Care 1 Practice Guidelines as Topic 1 Observation 1 Interferon-alpha 1 Immunoglobulin G 1 IMM-101 1 Disulfides 1 CVnCoV COVID-19 vaccine 1 COVID-19 Vaccines 1 BNT162 Vaccine 1 2019-nCoV Vaccine mRNA-1273 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04534725 2023-08-24

C-SMART

Peter MacCallum Cancer Centre, Australia

Phase 3 Completed

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡